Compare PDI & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDI | STVN |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 7.4B |
| IPO Year | N/A | 2021 |
| Metric | PDI | STVN |
|---|---|---|
| Price | $18.21 | $21.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.75 |
| AVG Volume (30 Days) | ★ 1.5M | 252.0K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 13.81% | 0.30% |
| EPS Growth | N/A | ★ 19.61 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $1,373,219,524.00 |
| Revenue This Year | N/A | $8.42 |
| Revenue Next Year | N/A | $8.77 |
| P/E Ratio | ★ N/A | $35.23 |
| Revenue Growth | N/A | ★ 6.97 |
| 52 Week Low | $15.45 | $17.81 |
| 52 Week High | $19.60 | $28.00 |
| Indicator | PDI | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 62.53 | 48.69 |
| Support Level | $18.03 | $20.09 |
| Resistance Level | $18.24 | $22.00 |
| Average True Range (ATR) | 0.12 | 0.66 |
| MACD | 0.07 | 0.21 |
| Stochastic Oscillator | 93.05 | 64.14 |
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.